Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks and then gradually titrated upward based on individual response and tolerability
Slabs and traction minimize patient movement, reducing REBOA sheath dislodgement (1020% risk) and balloon migration (515%)
Retrieved from Buckley, S
The findings come from a secondary analysis of a large randomized clinical trial involving more than 13,000 participants
)
)
)
US$ 29.50
US$ 26.36
US$ 21.21
US$ 25.24
US$ 29.30
